• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTABLE INFUSION SET 20G X 1.0IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTABLE INFUSION SET 20G X 1.0IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/26/2021
Type of Reportable Event Malfunction
Event or Problem Description
It was reported "patient port accessed w/20 g x 1¿ bard huber needle, had a levaquin infusing fluid leaking from tubing, noted 1 in huber needle cracked, port accessed on (b)(6) 2021.Pt refused val-guard; need to use teddy bears when line not infusing.Wasn¿t able to send until cultures were negative.".
 
Additional Manufacturer Narrative
The manufacturer has received the sample and is pending evaluation.Results are expected soon.A lot history review (lhr) review is not possible; the manufacturing lot number that was provided is incorrect/invalid.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, trend analysis, applicable previous investigation(s), sample (if available), and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a leaking infusion set was confirmed and the cause is currently under investigation.The product returned for evaluation was two 20ga x 1" powerloc max safety infsuion sets.The returned product samples were evaluated and the following observations were made: the first sample exhibited a fracture at the luer/tubing joint.The fracture surfaces of the damage contained striation-like patterns, radiating tear marks and material buckling which were indicative of flexural fatigue based failures, which may have been a contributing factor to the extension tubing damage.Repetitive mechanical stresses such as twisting and kinking may have contributed to the observed event; however, it appeared that additional unidentified factors also contributed.The device is a supplied component and the supplier has been notified of this event.The second sample did not exhibit leakage or damage and may have been returned as a reference sample.H3 other text : evaluation findings are in section h.11.
 
Event or Problem Description
It was reported "patient port accessed w/20 g x 1¿ bard huber needle, had a levaquin infusing fluid leaking from tubing, noted 1 in huber needle cracked, port accessed on (b)(6) 2021.Pt refused val-guard; need to use teddy bears when line not infusing.Wasn¿t able to send until cultures were negative.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC MAX POWER-INJECTABLE INFUSION SET 20G X 1.0IN
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
parque industrial colonial
salt lake city 84116
Manufacturer Contact
kayla olsen
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key13308959
Report Number3006260740-2022-00043
Device Sequence Number14693661
Product Code FPA
UDI-Device Identifier00801741089169
UDI-Public(01)00801741089169
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
K153440
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number0142010
Device Lot NumberAS7R061-INVALID
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/18/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/04/2022
Supplement Date Received by Manufacturer04/21/2022
Initial Report FDA Received Date01/20/2022
Supplement Report FDA Received Date04/22/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age2 YR
Patient SexFemale
Patient Weight12 KG
-
-